New insight into how tissue factor allosterically regulates Factor VIIa

被引:25
作者
Eigenbrot, C
Kirchhofer, D
机构
[1] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Physiol, San Francisco, CA 94080 USA
关键词
D O I
10.1016/S1050-1738(01)00139-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor VIIa (FVIIa) is the coagulation protease responsible for starting a cascade of proteolytic events that lead to thrombin generation, and hence, to fibrin deposition and platelet activation. As such, it has attracted interest as a target for clinical anticoagulant therapy. Commensurate with the critical importance of maintaining balance between thrombosis and hemostasis and FVIIa'S place at the beginning of the coagulation process, FVIIa is subject to a variety of biological and biochemical control mechanisms, among them allosteric influences exerted by cofactors, substrates, and inhibitors. Essential for the proteolytic activity of FVIIa is its cofactor, Tissue Factor (TF). Major progress in elucidating the key influence of TF was made when the TF.FVIla structure was determined in 1996. However, a molecular explanation of an important aspect of TF's influence-its effect on the active site-was not available until the recent determination of a FVII zymogen structure. In this review we discuss the significance of unprecedented differences between these two structures in understanding the regulation of this important enzyme. (C) 2002, Elsevier Science Inc.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 79 条
  • [1] DIFFERENTIAL EXPRESSION OF TISSUE FACTOR PROTEIN IN DIRECTIONAL ATHERECTOMY SPECIMENS FROM PATIENTS WITH STABLE AND UNSTABLE CORONARY SYNDROMES
    ANNEX, BH
    DENNING, SM
    CHANNON, KM
    SKETCH, MH
    STACK, RS
    MORRISSEY, JH
    PETERS, KG
    [J]. CIRCULATION, 1995, 91 (03) : 619 - 622
  • [2] ARBINI AA, 1994, BLOOD, V84, P2214
  • [3] Fibrin-rich and platelet-rich thrombus formation on neointima: Recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta
    Asada, Y
    Hara, S
    Tsuneyoshi, A
    Hatakeyama, K
    Kisanuki, A
    Marutsuka, K
    Sato, Y
    Kamikubo, Y
    Sumiyoshi, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) : 506 - 511
  • [4] FACTOR-VII BINDING TO TISSUE FACTOR IN RECONSTITUTED PHOSPHOLIPID-VESICLES - INDUCTION OF COOPERATIVITY BY PHOSPHATIDYLSERINE
    BACH, R
    GENTRY, R
    NEMERSON, Y
    [J]. BIOCHEMISTRY, 1986, 25 (14) : 4007 - 4020
  • [5] Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques - Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions
    Badimon, JJ
    Lettino, M
    Toschi, V
    Fuster, V
    Berrozpe, M
    Chesebro, JH
    Badimon, L
    [J]. CIRCULATION, 1999, 99 (14) : 1780 - 1787
  • [6] The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor
    Banner, DW
    DArcy, A
    Chene, C
    Winkler, FK
    Guha, A
    Konigsberg, WH
    Nemerson, Y
    Kirchhofer, D
    [J]. NATURE, 1996, 380 (6569) : 41 - 46
  • [8] TOPOLOGICALLY EQUIVALENT MUTATIONS CAUSING DYSFUNCTIONAL COAGULATION-FACTORS-VII ((294)ALA-]VAL) AND X((334)SER-]PRO)
    BERNARDI, F
    CASTAMAN, G
    REDAELLI, R
    PINOTTI, M
    LUNGHI, B
    RODEGHIERO, F
    MARCHETTI, G
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (07) : 1175 - 1177
  • [9] MOLECULAR DEFECTS IN CRM+ FACTOR-VII DEFICIENCIES - MODELING OF MISSENSE MUTATIONS IN THE CATALYTIC DOMAIN OF FVII
    BERNARDI, F
    LINEY, DL
    PATRACCHINI, P
    GEMMATI, D
    LEGNANI, C
    ARCIERI, P
    PINOTTI, M
    REDAELLI, R
    BALLERINI, G
    PEMBERTON, S
    WACEY, AI
    MARIANI, G
    TUDDENHAM, EGD
    MARCHETTI, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (03) : 610 - 618
  • [10] SYNTHETIC SUBSTRATES FOR HUMAN FACTOR-VIIA AND FACTOR-VIIA-TISSUE FACTOR
    BUTENAS, S
    RIBARIK, N
    MANN, KG
    [J]. BIOCHEMISTRY, 1993, 32 (26) : 6531 - 6538